相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polymorphism in Cytochrome P450 3A4 Is Ethnicity Related
Yelena Guttman et al.
FRONTIERS IN GENETICS (2019)
Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro
Xiao-Yang Zhou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro
Qian-Meng Lin et al.
INFECTION AND DRUG RESISTANCE (2019)
Effects of CYP3A4 Polymorphisms on Drug Addiction Risk Among the Chinese Han Population
Li Wang et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro
Ren-ai Xu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population
Guo-Xin Hu et al.
PHARMACOGENOMICS (2017)
Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro
Ping Fang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain
Guang-Tao Hao et al.
PHARMACOLOGICAL REPORTS (2014)
Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration
Romina Klimas et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Characterization of the genetic variation present in CYP3A4 in three South African populations
Britt Drögemöller et al.
Frontiers in Genetics (2013)
Analgesic Concentrations of Oxycodone - A Prospective Clinical PK/PD Study in Patients with Laparoscopic Cholecystectomy
Merja Kokki et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)
Analysis of CYP3A4 genetic polymorphisms in Han Chinese
Qing Zhou et al.
JOURNAL OF HUMAN GENETICS (2011)
Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of Anandamide
Matthew Pratt-Hyatt et al.
DRUG METABOLISM AND DISPOSITION (2010)
CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs
Keiko Maekawa et al.
DRUG METABOLISM AND DISPOSITION (2010)
Role of oxycodone and oxycodone/naloxone in cancer pain management
Wojciech Leppert
PHARMACOLOGICAL REPORTS (2010)
Comparison of effects and plasma concentrations of opioids between elderly and middle-aged patients after cardiac surgery
A. Pesonen et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2009)
Gender and interindividual variability in pharmacokinetics
Jean-Marie Nicolas et al.
DRUG METABOLISM REVIEWS (2009)
Defective Activity of Recombinant Cytochromes P450 3A4.2 and 3A4.16 in Oxidation of Midazolam, Nifedipine, and Testosterone
Mitsue Miyazaki et al.
DRUG METABOLISM AND DISPOSITION (2008)
Structural basis for ligand promiscuity in cytochrome P450 3A4
Marika Ekroos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population
Jing Du et al.
PHARMACOGENOMICS (2006)
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites
Bojan Lalovic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip
CH Liu et al.
PHARMACOGENOMICS (2005)
Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes
B Lalovic et al.
DRUG METABOLISM AND DISPOSITION (2004)
The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-Å resolution
JK Yano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical importance of the cytochromes P450
DW Nebert et al.
LANCET (2002)
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba et al.
PHARMACOGENETICS (2002)
Identification and functional characterization of eight CYP3A4 protein variants
R Eiselt et al.
PHARMACOGENETICS (2001)
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
F Sata et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Mammalian microsomal cytochrome P450 monooxygenase: Structural adaptations for membrane binding and functional diversity
PA Williams et al.
MOLECULAR CELL (2000)
分享论文
